HIF1A and neoplasm: Ginsenoside Rh2 inhibits the aerobic glycolysis of tumors, including the uptake of glucose and the production of lactate, by targeting and down-regulating the expression of HIF-1α, which significantly inhibits tumor proliferation and migration (105).